IT1229563B - Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione. - Google Patents

Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.

Info

Publication number
IT1229563B
IT1229563B IT8919705A IT1970589A IT1229563B IT 1229563 B IT1229563 B IT 1229563B IT 8919705 A IT8919705 A IT 8919705A IT 1970589 A IT1970589 A IT 1970589A IT 1229563 B IT1229563 B IT 1229563B
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical compositions
compositions containing
type compounds
Prior art date
Application number
IT8919705A
Other languages
English (en)
Other versions
IT8919705A0 (it
Inventor
Peter Literati Nagy
Maria Boros
Jeno Szilbereky
Istvan Racz
Gyongyver Soos
Miklos Koller
Alan Pinter
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of IT8919705A0 publication Critical patent/IT8919705A0/it
Application granted granted Critical
Publication of IT1229563B publication Critical patent/IT1229563B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT8919705A 1988-03-09 1989-03-09 Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione. IT1229563B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881131A HU199775B (en) 1988-03-09 1988-03-09 Process for production of formed by fatty acids salts of amin acids and medical compositions containing them

Publications (2)

Publication Number Publication Date
IT8919705A0 IT8919705A0 (it) 1989-03-09
IT1229563B true IT1229563B (it) 1991-09-04

Family

ID=10952971

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8919705A IT1229563B (it) 1988-03-09 1989-03-09 Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.

Country Status (16)

Country Link
JP (1) JP2751068B2 (it)
KR (1) KR0140993B1 (it)
AT (1) AT398073B (it)
BE (1) BE1003663A3 (it)
CA (1) CA1339147C (it)
CH (1) CH678851A5 (it)
DE (1) DE3907688C2 (it)
ES (1) ES2010439A6 (it)
FI (1) FI93949C (it)
FR (1) FR2628419B1 (it)
GB (1) GB2216522B (it)
HU (1) HU199775B (it)
IT (1) IT1229563B (it)
LU (1) LU87470A1 (it)
NL (1) NL8900573A (it)
SE (1) SE508603C2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
SG44524A1 (en) * 1991-06-24 1997-12-19 Adelaide Children S Hospital Methods and compositions of treating malaria and other diseases
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
HU227588B1 (hu) 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
US8628756B2 (en) 2005-12-30 2014-01-14 Revance Therapeutics, Inc. Arginine heteromers for topical administration
EP3236782B1 (en) * 2014-12-23 2020-02-05 Evonik Operations GmbH Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2019034698A1 (en) * 2017-08-15 2019-02-21 Evonik Technochemie Gmbh TABLET WITH HIGH ACTIVE INGREDIENT CONTENT OF OMEGA-3 FATTY ACID AMINO ACID SALTS
WO2021151201A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181704A1 (en) * 1972-02-04 1973-12-07 Univ Minnesota Arbo-virus infections vaccines - contg 10-22c unsatd fatty acids or salts pref of petroselinic acid
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB8327911D0 (en) * 1983-10-19 1983-11-23 Ciba Geigy Ag Salts as corrosion inhibitors
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
FR2587900B1 (fr) * 1985-10-01 1988-10-07 Morelle Jean Associations acides gras-acides amines basiques, douees de proprietes emollientes, emulsifiantes et antioxydantes, destinees a la cosmetique, la dermatologie et l'alimentation
JPS63230632A (ja) * 1987-03-20 1988-09-27 Nippon Oil & Fats Co Ltd リポキシゲナ−ゼ代謝刺激剤
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
SE508603C2 (sv) 1998-10-19
BE1003663A3 (fr) 1992-05-19
FI891144A (fi) 1989-09-10
FR2628419A1 (fr) 1989-09-15
GB2216522B (en) 1992-01-02
SE8900827L (sv) 1989-09-10
HUT49564A (en) 1989-10-30
DE3907688C2 (de) 1996-09-05
IT8919705A0 (it) 1989-03-09
JP2751068B2 (ja) 1998-05-18
DE3907688A1 (de) 1989-09-21
KR890014451A (ko) 1989-10-23
FI93949B (fi) 1995-03-15
ES2010439A6 (es) 1989-11-01
KR0140993B1 (ko) 1998-07-01
FI93949C (fi) 1995-06-26
ATA50989A (de) 1994-01-15
LU87470A1 (fr) 1990-10-02
SE8900827D0 (sv) 1989-03-09
JPH024746A (ja) 1990-01-09
CA1339147C (en) 1997-07-29
FR2628419B1 (fr) 1992-02-14
NL8900573A (nl) 1989-10-02
AT398073B (de) 1994-09-26
HU199775B (en) 1990-03-28
CH678851A5 (it) 1991-11-15
GB8905384D0 (en) 1989-04-19
GB2216522A (en) 1989-10-11
FI891144A0 (fi) 1989-03-09

Similar Documents

Publication Publication Date Title
IT1225762B (it) Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono.
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
IT1229563B (it) Composti tipo sali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
IT1232303B (it) Composti di diammina e loro sali, procedimenti per la loro preparazio ne e composizioni farmaceutiche contenenti detti composti e i loro sa li
DK209384A (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
IT8748689A0 (it) Derivati di azaspirodecano,loro sali,procedimento di preparazione,applicazione quali medicamenti e composizioni che li contengono
IT1138155B (it) Composti citostatici,procedimento per la loro preparazione e composizioni farmaceutiche contenenti gli stessi
IT1177981B (it) Amminociclopentani, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione
IT1208533B (it) Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1172268B (it) Piperidinoguanidine sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8520420A0 (it) Sali di l-fosfoserina, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1237115B (it) Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
IT1204380B (it) Composti tiofensolfonamidici,composizioni erbicide che li contengono e procedimento per la loro preparazione
IT1205817B (it) Benzammidi sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8820854A0 (it) Sali di glicosaminoglicani, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1217192B (it) Tioeteri chinolinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8721255A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8820468A0 (it) Piridobenzodiazepinoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8422042A0 (it) Composti antibatterici, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1215299B (it) Diidropiridine 2-tiosostituite, metodo per la loro preparazione e composizione farmaceutiche che le contengono.
IT8322133A0 (it) Derivati della pantenina, loro sali, procedimento per la loro preparazione e composizioni farmaceutiche che li contenono.
IT8619564A1 (it) Omoeburnamenina e epi-21-omoeburnamenina, loro sali e composizioni che le contengono
IT8519065A0 (it) Composti con attivita' antitossica ed antianemica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1148621B (it) 3-alchil,4-carbossi butirrilcarnitine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8320672A0 (it) Nuovi composti ad attivita'antineoplastica, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970327